ABRAMS, K. et al. Self-Administrtion of Alcohol Before and After a Public Speaking Challenge by Individuals with Social Phobia. Psychol Addict Behav., v. 16, n. 2, p. 121-128, Jun. 2002.
FIDALGO, T. M. et al. Validation of a short version of the Revised Drug Use Screening Inventory (DUSI-R) in a Brazilian sample of adolescents. American Journal on Addictions, 2010.
FIDALGO, T. M.; SILVEIRA, E. D.; SILVEIRA, D. X. Drug use among adolescents in Brazil. In: Focus on Adolescent Behavior Research. Ed. Nova Publisher, 2007.
______. Psychiatry comorbidities related to alcohol use among adolescents. American Journal of Drug and Alcohol Abuse, v. 34, n. 1, 2008.
HARDING, T. W. et al. Mental Disorders in primary health care: a study of their frequency and diagnosis in four development countries. Psychological Medicine, n. 10, p. 231-241, 1980.
KAMPMAN et al. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend, n. 75, p. 233-240, 2004.
KARILA et al. New treatments for cocaine dependence. Int J Neuropsychopharmacol, n. 11, 2008.
KESSLER, R. C. et al. Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry, n. 51, p. 8-19, 1994.
KHANTZIAN, E. J. The Self-Medication Hypothesis of Addict Disorders: Focus on Heroin and Cocaine Dependence. American J Psychiatry, n. 142, p. 1259-1264, 1985.
KLEBER et al. Treatment of Patients With Substance Use Disorders, Second Edition. American J Psychiatry, n. 164, p. 4, April 2007 Supplement.
KUSHNER, M. G. et al. Anxiety Mediates the Association Between Anxiety Sensitivity and Coping-Related Drinking Motives in Alcoholism Treatment Patients. Addict Behav., v. 26, n. 6, p. 869-885, Nov-Dec., 2001.
KUSHNER, M. G.; ABRAMS, K.; BORCHARDT, C. The Relationship between Anxiety Disorders and Alcohol Use Disorders: a Review of Major Perspectives and Findings. Clin Psychol Rev., v. 20, n. 2, p. 149-171, Mar. 1999.
LIMA et al. Carbamazepine for cocaine dependence (Cochrane Review). The Cochrane Library, Issue 4, 2007.
MARLATT, G. A. Redução de Danos: estratégias práticas para lidar com comportamentos de alto risco. Porto Alegre: Editora Artes Médicas Sul, 1999.
OLIEVENSTEIN, C. La clinique du toxicomane. Bagedis: Éd. Universitaires, 1987, p. 45-61.
REGIER, D. A. et al. Comorbidity of Mental Disorder with Alcohol and other Drug Abuse. Results from Epidemiologic Catchment Area Study. J Am Med Association, v. 264, n. 19, p. 2511-2518, 1990.
SCHAEFER, M.; HEINZ, A.; BACKMUND, M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction., n. , 99, p. 1167-1175, 2004.
SILVEIRA, D. X. Drogas, uma compreensão psicodinâmica das farmacodependências. São Paulo: Ed. Casa do Psicólogo, 1995.
______; JORGE, M. R. Comorbidade psiquiátrica em dependentes de substâncias psicoativas: resultados preliminares. Rev. Bras. Psiquiatr., v. 21, n. 3, p. 145-151, jul./set. 1999.
______; MOREIRA, F. G. (Org.). Panorama atual de drogas e dependências. São Paulo: Editora Atheneu, 2005.